Cargando…
Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections
[Image: see text] When the nucleoside analogue acyclovir was introduced in the early 1980s, it presented a game-changing treatment modality for herpes simplex virus infections. Since then, work has been ongoing to improve the weaknesses that have now been identified: a narrow time window for therape...
Autores principales: | Birkmann, Alexander, Bonsmann, Susanne, Kropeit, Dirk, Pfaff, Tamara, Rangaraju, Manickam, Sumner, Melanie, Timmler, Burkhard, Zimmermann, Holger, Buschmann, Helmut, Ruebsamen-Schaeff, Helga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620171/ https://www.ncbi.nlm.nih.gov/pubmed/36202389 http://dx.doi.org/10.1021/acs.jmedchem.2c00668 |
Ejemplares similares
-
No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy
por: Edlefsen, Paul T., et al.
Publicado: (2016) -
1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series
por: Albrecht, Kim WorkowskiJoerg, et al.
Publicado: (2021) -
Alopecia Following Oral Acyclovir for the Treatment of Herpes Simplex Keratitis
por: Sharma, Ashok, et al.
Publicado: (2014) -
Neonatal Herpes Simplex Fulminant Hepatitis Successfully Treated with Acyclovir
por: Abuhasna, Said D., et al.
Publicado: (2012) -
Necrotizing Keratitis Caused by Acyclovir-Resistant Herpes Simplex Virus
por: Toriyama, Koji, et al.
Publicado: (2014)